Jamison Private Wealth Management, Inc. Biogen Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $602 Billion
- Q2 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 162 shares of BIIB stock, worth $36,616. This represents 0.01% of its overall portfolio holdings.
Number of Shares
162
Previous 365
55.62%
Holding current value
$36,616
Previous $78.7 Million
52.28%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,050Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.75 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.67 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.2 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.53 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.17 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...